Did you know? The total GLP-1 market is projected to reach a potential $200 billion by 2031. As such, oral solid dose (OSD) formulations are poised to gain significant traction. This shift demands manufacturing partners with proven expertise in: 💊Specialized potent compound handling ⏳ Modified release technology 🎯 Precise quality control systems 📈 Continuity of supply https://www.lannettcdmo.com/advanced-formulation-analytical-services/

We offer adaptable manufacturing options to accommodate varying production scales and timelines for our partners. Contact us to find out more- https://www.lannettcdmo.com/pharmaceutical-manufacturing/

Outsourcing to a CDMO can significantly reduce operational costs and increase efficiency. By partnering with Lannett CDMO, companies can leverage our expertise and infrastructure, allowing them to focus on their core competencies. https://pharma-contractor-manufacturer.mystrikingly.com/blog/the-growing-importance-of-pharma-contract-manufacturing-services-88ea68f0-e173-424a-91ed-90f889848b0f #PharmaOutsourcing #OperationalEfficiency #CostReduction #PharmaceuticalManufacturing#BusinessPartnership #Lannett #LannettCDMO

Accelerate Your Drug to Market. Overcome development challenges and speed up your launch with a good CDMO partnership. Discover how a CDMO partnership can help overcome development challenges and speed up market launch. https://www.lannettcdmo.com/pharmaceutical-contract-manufacturer/

Navigating the Complex World of Pharmaceutical Regulatory Support https://www.lannettcdmo.com/regulatory-support/

Behind every pill lies meticulous precision and unwavering commitment to quality. Welcome to the heart of pharmaceutical manufacturing. https://www.lannettcdmo.com/

Lannett CDMO utilizes wet high-shear granulation. This is when a liquid binder is added to the powder mixture to form granules. This process can be used for producing: Tablets: For granules with good flow properties and compressibility. Capsules: For uniformity and flowability for capsule filling. Controlled Release: For specific release profiles with set parameters and properties. Got a particular Oral Solid Dosage form in mind? Talk to us to find out more. https://www.lannettcdmo.com/advanced-formulation-analytical-services/ #capsulefilling #granules #cdmo #oralsoliddosage #lannett #lannettcdmo

Lannett CDMO utilizes wet high-shear granulation. This is when a liquid binder is added to the powder mixture to form granules. This process can be used for producing: Tablets: For granules with good flow properties and compressibility. Capsules: For uniformity and flowability for capsule filling. Controlled Release: For specific release profiles with set parameters and properties. Got a particular Oral Solid Dosage form in mind? Talk to us to find out more. https://www.lannettcdmo.com/advanced-formulation-analytical-services/

Lannett’s laboratories are well-equipped and spacious; our walk-in and reach-in stability chambers can be validated at a variety of conditions, the common being: - Long-term (25°C and 60%RH or 25°C and 40%RH) - Intermediate (30°C and 65% RH) - Accelerated (40°C and 75%RH or 40°C and 25%RH) Our laboratory capabilities are all about providing solutions fitted to your needs. https://www.lannettcdmo.com/advanced-formulation-analytical-services/

High-shear granulators are specialized equipment particularly used for producing oral solid dosage forms like tablets. These machines combine blending and granulation in one process, making them highly efficient for producing uniform granules. Thanks to advanced machines like these, Lannett CDMO is able to achieve high product yield rate and on-time delivery. https://www.lannettcdmo.com/pharmaceutical-contract-manufacturer/ #OralSolidDoses #Granulation #OnTimeDelivery #Lannett hashtag#LannettCDMO